Clinical Report: The Missing Step in Pediatric Lupus Care

Overview

A survey study reveals significant gaps in cognitive screening practices for children with childhood-onset systemic lupus erythematosus (SLE). Despite high awareness of cognitive dysfunction's prevalence, standardized evaluations are rarely conducted, highlighting barriers in routine care.

Background

Cognitive dysfunction is a common complication in childhood-onset SLE, affecting 30% to 60% of patients and leading to impaired academic performance and reduced quality of life. Despite the recognized importance of cognitive assessment, routine screening is not consistently implemented in clinical practice. Understanding and addressing the barriers to cognitive evaluation is crucial for improving patient outcomes.

Data Highlights

The survey included 109 rheumatologists and trainees, revealing that while 94% acknowledged cognitive dysfunction as common in childhood-onset SLE, only 61% regularly inquire about cognitive concerns, and merely 8% utilize comprehensive neuropsychological evaluations.

Key Findings

• 94% of surveyed clinicians believe cognitive dysfunction is common in childhood-onset SLE.
• 93% support routine cognitive screening based on medical literature.
• Only 61% regularly ask about cognitive concerns during visits.
• 27% reported using any standardized screening method.
• 8% routinely use comprehensive neuropsychological evaluations.
• Barriers include time constraints, uncertainty about tools, and limited access to services.

Clinical Implications

Clinicians should prioritize cognitive screening in routine assessments for children with SLE, despite existing barriers. Developing streamlined screening tools and improving access to neuropsychological services are essential steps to enhance patient care.

Conclusion

The findings underscore a critical gap between the recognition of cognitive dysfunction in childhood-onset SLE and its practical assessment in clinical settings. Addressing these challenges is vital for improving the management of cognitive health in affected patients.

References

1. Cognitive Screening and Neuropsychological Evaluation in Children and Young Adults With Childhood‐Onset Systemic Lupus Erythematosus: A Survey of Rheumatologists - PMC, 2023 -- Title
2. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023 -- Title
3. Clinical Rheumatology — Chimeric Antigen Receptor T Cell Therapy for Pediatric Systemic Lupus Erythematosus
4. Clinical Rheumatology — Management and Long-Term Outcomes in Children with Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS): A Review of Case Studies
5. The ASCO Post — Nonadherence With Maintenance Medication an Issue in Children With Leukemia
6. Clinical Rheumatology — The Advent of Biologic Therapies for Systemic Lupus Erythematosus Management
7. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
8. Cognitive Screening and Neuropsychological Evaluation in Children and Young Adults With Childhood‐Onset Systemic Lupus Erythematosus: A Survey of Rheumatologists - PMC
9. Biomarkers in Pediatric Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review